Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

about

iTRAQ-Based Proteomics Investigation of Aqueous Humor from Patients with Coats' Disease.

P2860

Q36077801-511A8AF4-071B-46A0-8029-78F98266EBDC

P2860

Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

Item

http://www.wikidata.org/entity/Q42030825

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

@en

Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

@nl

type

Item

label

Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

@en

Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

@nl

prefLabel

Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

@en

Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

@nl

P1476

Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

@en

P2093

Elizabeth R Seaquist

http://www.w3.org/2001/XMLSchema#string

Gary L Nelsestuen

http://www.w3.org/2001/XMLSchema#string

Julie A Kirihara

http://www.w3.org/2001/XMLSchema#string

Matthew S Wroblewski

http://www.w3.org/2001/XMLSchema#string

Nicole E B Skinner

http://www.w3.org/2001/XMLSchema#string

P2860

Exact localization of the familial dysbetalipoproteinemia associated HpaI restriction site in the promoter region of the APOC1 gene

Apolipoprotein C-1 inhibits the hydrolysis by phospholipase A2 of phospholipids in liposomes and cell membranes

Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL

Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway

An improved RSP method to detect HpaI polymorphism in the apolipoprotein C-1 gene promoter

Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family

Biochemical properties of recombinant prolyl dipeptidases DPP-IV and DPP8

Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses

Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein.

Plasma protein profiling: unique and stable features of individuals.

P2888

s13300-015-0123-1

P304

395-401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1007/S13300-015-0123-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280328898

http://www.w3.org/2001/XMLSchema#string

P698

26198273

http://www.w3.org/2001/XMLSchema#string

P932

4575309

http://www.w3.org/2001/XMLSchema#string

Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

about

P2860

P2860

Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932